Meulebrouck, S., Scherrer, V., Boutry, R., Toussaint, B., Vaillant, E., Dechaume, A., . . . Bonnefond, A. (2024). Pathogenic monoallelic variants in GLIS3 increase type 2 diabetes risk and identify a subgroup of patients sensitive to sulfonylureas. Diabetologia, 67(2), 327-332. https://doi.org/10.1007/s00125-023-06035-x

Meulebrouck, Sarah, et al. "Pathogenic Monoallelic Variants in GLIS3 Increase Type 2 Diabetes Risk and Identify a Subgroup of Patients Sensitive to Sulfonylureas." Diabetologia 67, no. 2 (2024): 327-332. https://doi.org/10.1007/s00125-023-06035-x.

Meulebrouck, Sarah, et al. "Pathogenic Monoallelic Variants in GLIS3 Increase Type 2 Diabetes Risk and Identify a Subgroup of Patients Sensitive to Sulfonylureas." Diabetologia, vol. 67, no. 2, 2024, pp. 327-332, https://doi.org/10.1007/s00125-023-06035-x.